StageSeries A | Alive
Last Raised$5.46M | 1 yr ago
About YJ Cerapeutics
YJ Cerapeutics researches and develops smart neural stem cell therapies for patients with intractable neurological diseases. The company's core technologies include direct conversion by small molecules, neural stem cell therapy, and small molecule compounds. It serves patients with chronic spinal cord injuries. It was founded in 2021 and is based in Seoul, South Korea.
Missing: YJ Cerapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: YJ Cerapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
YJ Cerapeutics Patents
YJ Cerapeutics has filed 1 patent.
The 3 most popular patent topics include:
- Designer drugs
- Neurological disorders
YJ Cerapeutics Frequently Asked Questions (FAQ)
When was YJ Cerapeutics founded?
YJ Cerapeutics was founded in 2021.
Where is YJ Cerapeutics's headquarters?
YJ Cerapeutics's headquarters is located at 204, Kyunghee University Campus Town, Seoul.
What is YJ Cerapeutics's latest funding round?
YJ Cerapeutics's latest funding round is Series A.
How much did YJ Cerapeutics raise?
YJ Cerapeutics raised a total of $5.91M.
Who are the investors of YJ Cerapeutics?
Investors of YJ Cerapeutics include QUAD Investment Management, Saehan Venture Capital and Ryukyung PSG Asset Management.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.